Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Mayhew, Anna GMoat, Dionne
McDermott, Michael P
Eagle, Michelle
Griggs, Robert C
King, Wendy M
James, Meredith K
Muni-Lofra, Robert
Shillington, Alison
Gregson, Sarah
Pallant, Lindsey
Skura, Christy
Staudt, Loretta A
Eichinger, Katy
McMurchie, Heather
Rabb, Rosanna
Di Marco, Marina
Brown, Sarah
Zanin, Riccardo
Arnoldi, Maria Teresa
McIntyre, Melissa
Wilson, Amelia
Alfano, Lindsay N
Lowes, Linda P
Blomgren, Colleen
Milev, Evelin
Iodice, Mario
Pasternak, Amy
Chiu, Angela
Lehnert, Ilka
Claus, Nicole
Dieruf, Kathy A
Rolle, Enrica
Nicorici, Alina
Andres, Barbara
Hobbiebrunken, Elke
Roetmann, Gerda
Kern, Victoria
Civitello, Matthew
Vogt, Sibylle
Hayes, Melissa J
Scholtes, Cheryl
Lacroix, Catherine
Gunn, Tara
Warner, Sinead
Newman, Jennifer
Barp, Andrea
Kundrat, Katherine
Kovelman, Staci
Powers, Penny J
Guglieri, Michela
Publication date
2022-02-26Subject
Paediatrics
Metadata
Show full item recordAbstract
The purpose of this study was to quantitate motor performance in 196 genetically confirmed steroid-naïve boys with Duchenne muscular dystrophy (DMD), to evaluate the test-retest reliability of measures of motor performance in young DMD boys, and to assess correlations among the different functional outcomes including timed tests. Boys aged 4-7 years were recruited in the FOR-DMD study, a comparative effectiveness study of different steroid regimens in DMD. Eligible boys had to be able to rise from the floor independently and to perform pulmonary function testing consistently. The boys were evaluated with standardized assessments at the screening and baseline visits at 32 sites in 5 countries (US, UK, Canada, Italy, Germany). Assessments included timed rise from floor, timed 10 m walk/run, six-minute walk distance, North Star Ambulatory Assessment (NSAA) and forced vital capacity (FVC). Mean age at baseline was 5.9 years (range 4.1-8.1 years). Test-retest reliability was high for functional assessments, regardless of time lag between assessments (up to 90 days) and for the majority of age groups. Correlations were strong among the functional measures and timed tests, less so with FVC. Physiotherapy measures are reliable in a young, steroid-naïve population and rise from floor velocity appears to be a sensitive measure of strength in this population.Citation
Mayhew AG, Moat D, McDermott MP, Eagle M, Griggs RC, King WM, James MK, Muni-Lofra R, Shillington A, Gregson S, Pallant L, Skura C, Staudt LA, Eichinger K, McMurchie H, Rabb R, Di Marco M, Brown S, Zanin R, Arnoldi MT, McIntyre M, Wilson A, Alfano LN, Lowes LP, Blomgren C, Milev E, Iodice M, Pasternak A, Chiu A, Lehnert I, Claus N, Dieruf KA, Rolle E, Nicorici A, Andres B, Hobbiebrunken E, Roetmann G, Kern V, Civitello M, Vogt S, Hayes MJ, Scholtes C, Lacroix C, Gunn T, Warner S, Newman J, Barp A, Kundrat K, Kovelman S, Powers PJ, Guglieri M; Muscle Study Group and TREAT-NMD. Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2022 Jun;32(6):460-467. doi: 10.1016/j.nmd.2022.02.012. Epub 2022 Feb 26Type
ArticleAdditional Links
https://www.sciencedirect.com/journal/neuromuscular-disordersPMID
35618576Journal
Neuromuscular DisordersPublisher
Pergamon Pressae974a485f413a2113503eed53cd6c53
10.1016/j.nmd.2022.02.012